Moffitt in the News - Media Coverage of Moffitt Cancer Center

Where You Are:

Feb. 20-26, 2015


Warren Elly, in the fight of his life against cancer

Tampa Bay Times – Feb. 26
Moffitt confirms the original diagnosis, Adrenal Cortical Carcinoma (ACC)

Honoring our healthcare heroes
The Weekly Challenger – Feb. 26

The men of the hour were also recognized for their unwavering dedication to healthcare and helping the underserved and voiceless throughout the community.  Among them was Dr. B. Lee Green. Although he was unable to make the banquet, Green is known for his work with Moffitt Cancer Center where he serves as a senior member. Green focuses his work on recognizing cancer disparities, especially among minority populations.

Courage in the face of cancer
The Observer News – Feb. 26

T-cell lymphoma can be either aggressive or slow-growing. Because there are so many different types of T-cell lymphoma, treatment varies. Standard lymphoma therapies include chemotherapy, radiation, stem cell transplantation and surgery. In Lorraine’s case, doctors recommended stem cell transplantation, a process she endured over a two-year period at the Moffitt Cancer Center in Tampa.

Student pens winning Black History Month essay
The Observer News – Feb. 26

“These conversations were meaningful to me because no one had ever had these talks with me before and I did not really know what it meant to be a leader,” Juwuan wrote. “I began to look for events in which I could participate. I worked at a nursing home near my house, I participated in outreach programs at the Moffitt Cancer Center, and I worked during the Relay for Life fundraising events.”

Scope superbug: How long did the FDA know about problem?
CNN – Feb. 25

“This is clearly a matter that needs addressing,” said Dr. John Greene, an infectious disease expert at the Moffitt Cancer Center who published an article in 2013 on a duodenoscope outbreak in Tampa. “We really should have done this sooner.”

Experimental treatment helps cancer patient beat grim diagnosis
FOX-13 – Feb. 25

“This is really a game changer,” said Dr. Ben Creelan, Neil’s oncologist at Moffitt Cancer Center. Creelan is testing an infusion of two drugs. The first is treats other types of cancer; the second shrinks tumors.

Robotic surgery saving lives
WTSP, 10 News – Feb. 25

Faster recovery, less blood loss and a minimally invasive procedure are what patients are experiencing after undergoing robotic surgery.

Beloved runner leaves behind an Army of supporters
News-Press – Feb. 25

Proceeds from this event are being donated to Barbara’s Friends and The Moffitt Cancer Center. Since its inception, the Hooters Half Marathon has raised more than $200,000 for cancer research.

Hillsborough County news in brief: Shamrock run kicks off at new location
Tampa Bay Times – Feb. 25

The Brandon Running Association will stage the 37th Annual Shamrock Classic 10K & 5K fundraiser on March 14. The races will begin and end at O’Brien’s Irish Pub, 701 W Lumsden Ave. Proceeds will benefit the H. Lee Moffitt Cancer Center. Raceday registration starts at 7 a.m. with the 10K race set to begin at 8 a.m. and the 5K set for 9 a.m.

FOLFIRINOX Plus Radiation Renders Some Locally Advanced Pancreatic Cancer Patients Resectable
The ASCO Post – Feb. 25

Investigators from H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, have reported an approach to pancreatic cancer that downstages some locally advanced patients to borderline resectable status and achieves a negative surgical margin rate exceeding 96%. The study earned a Merit Award at the 2015 Gastrointestinal Cancers Symposium, where Eric A. Mellon, MD, PhD, a radiation oncology resident at Moffitt, presented the findings.

International Society of Geriatric Oncology: At the Forefront of Physician Education and Research Dissemination in Geriatric Oncology
The ASCO Post – Feb. 25

Awards were presented to outstanding investigators at the meeting. The SIOG 2014 Paul Calabresi Award was given to Martine Extermann, MD, PhD (Moffitt Cancer Center, Tampa, Florida) for her longstanding and major achievements.

Surgery Plus Immunotherapy Improves Survival in Melanoma Patients With Gastrointestinal Metastases
The ASCO Post – Feb. 25

Similarly, in a study considered the largest series of its kind, researchers from Moffitt Cancer Center, Tampa, Florida, reported outcomes for melanoma patients who underwent resection of lesions isolated to the pancreas.

Invitan a encuentro educativo sobre cáncer
La Perla del Sur – Feb. 25

Para hablar sobre el cáncer y romper los mitos asociados a esta condición, la Universidad de Ciencias de la Salud de Ponce y el Moffitt Cancer Center realizarán un taller educativo dirigido a la comunidad, este sábado, 28 de febrero a las 8:30 de la mañana en las instalaciones del Salvation Army en Ponce.

WHAT TO DO, WHERE TO GO
Fort Myers Florida Weekly – Feb. 25

Benefit Marathon - The 2015 Hooters Half Marathon starts at 7 a.m. Proceeds benefit The Moffitt Cancer Center and Barbara’s Friends - Golisano Children’s Hospital Cancer Fund. Participants can run individually or as a two-person relay team. 

Experimental treatment teaches body to fight cancer cells
FOX-13 – Feb. 24

That’s when Dr. Amod Sarnaik, a surgical oncologist at Moffitt Cancer Center, offered Britta an experimental therapy that would change her life. “The tumor is still completely gone…so Britta’s had a complete response to the treatment,” Dr. Sarnaik says as he shows us Britta’s most recent MRI.

Chasing ‘The Cure’
Healthcare IT News – Feb. 24

At Moffitt Cancer Center in Tampa, Fla., researchers are working with Oracle on an informatics platform that will help make cancer care more targeted, more personal. As Mark Hulse, RN, senior vice president and CIO at Moffitt, put it back in 2011 as the platform was being rolled out, it will “enable us to surmount two fundamental health science informatics challenges – data integration and analysis – to identify predictive biomarkers that will lead to more personalized treatments for our patients.”

Moffitt researchers participate in HPV international phase 2/3 trial
National Cancer Institute – Feb. 23

A pivotal international phase 2/3 clinical trial involving Moffitt Cancer Center faculty demonstrated that vaccination with Gardasil 9 protects against nine HPV types, seven of which cause most cases of cervical, vulvar, and vaginal disease. The trial data indicate that if populations are vaccinated with Gardasil 9 approximately 90 percent of all cervical cancers worldwide can be prevented.

Moffitt gets $250,000 to study ovarian cancer
ABC Action News – Feb. 23

Janis Carpenter, 72, was recognized at a news conference at Moffitt Cancer Center. She was chosen by staff there to represent the older ovarian cancer patients whose chances of survival are, unfortunately, much less. Martine Extermann, M.D., PhD, at Moffitt Cancer Center, says, “You can see that when in younger women, 75 percent are alive in five years. And that if you are 75 or older, it’s not even 20 percent.”

Women’s Final Four Brings Cancer Research Grant To Town
WUSF News – Feb. 23

When the NCAA Women’s Final Four comes to town, cancer researchers benefit. Since 2009, the Kay Yow Cancer Fund has awarded a women’s cancer research grant to a research institution in the city hosting the NCAA Women’s Final Four. Monday, Moffitt Cancer Center Professor of Oncology and Medicine Dr. Martine Extermann received the $250,000 grant.

Moffitt Cancer Center wins grant for ovarian cancer research
The Associated Press – Feb. 23

Moffitt Cancer Center in Tampa is receiving a $250,000 grant to continue research into ovarian cancer in older women, for whom the disease often is more aggressive. The money comes from the Kay Yow Cancer Fund in partnership with The V Foundation for Cancer Research. On Monday, the partners also announced a campaign aimed at raising another $1 million in support of ovarian cancer research at Moffitt.

Moffitt wins $250,000 grant for ovarian cancer research
Tampa Bay Times – Feb. 23

Moffitt Cancer Center is receiving a $250,000 grant to continue research into ovarian cancer in older women, for whom the disease often is more aggressive. The money comes from the Kay Yow Cancer Fund in partnership with The V Foundation for Cancer Research. The partners also announced a campaign aimed at raising another $1 million in support of ovarian cancer research at Moffitt.

NCAA women's Final Four expected to be a boon for Tampa
Tampa Bay Times – Feb. 23

“Of all the cities we’ve been in, this city has a phenomenal partnership with all of the most important pieces of the puzzle to put together a final four,” Browne said at a news conference held at Moffitt Cancer Center on Monday.

Women’s Final Four helps Moffitt score $250,000 grant
The Tampa Tribune – Feb. 23

As the National Collegiate Athletic Association prepares to bring the Women’s Final Four to Tampa, a prominent cancer research fund named for a former coach has announced it is giving the Moffitt Cancer Center a $250,000 grant.

Tampa Bay area touted for medical tourism
The Tampa Tribune – Feb. 23

Pinellas County Commissioner John Morroni said it makes sense to incorporate the area’s elite health care institutions into a marketing package with familiar tourist attractions. The Bay area enjoys a reputation for top-flight medical care at institutions such as the Moffitt Cancer Center and Tampa General Hospital in Tampa and All Children’s Hospital in St. Petersburg.

Why These Guys Might Be More Vulnerable to a Scary STD
Men’s Health – Feb. 23

Sexually transmitted diseases are often thought of as a young person’s problem—15- to-24-year-olds do make up half of all new cases—but some may be more dangerous the grayer you get. Older men who catch a certain type of human papillomavirus (HPV) may be less able to clear it from their bodies, researchers from the Moffitt Cancer Center found. 

Dr. Sotomayor on Precision Medicine for the Prevention of Cancer
OncLive – Feb. 23

Eduardo Sotomayor, MD, the Susan and John Sykes Endowed Chair in Hematologic Malignancies at Moffitt Cancer Center, discusses the future of personalized medicine in lymphoma.

Researchers complete Gardasil 9 HPV vaccine’s international phase 2/3 trial
Pharmaceutical Business Review – Feb. 23

The international phase 2/3 clinical trial, which involved Moffitt Cancer Center faculty, demonstrated that Gardasil 9 vaccination can protect against nine HPV types, seven of which cause most cases of cervical, vulvar, and vaginal disease.

Cosmetologists honored for helping cancer patients feel beautiful again
The Villages Daily Sun – Feb. 21

Five months ago, a cancer diagnosis devastated Eleanor Tagner. In the wake of her treatment, the Village Alhambra resident discovered the nonprofit Look Good, Feel Better beauty program at Moffitt Cancer Center at The Villages, on The Villages Regional Hospital’s main campus. Through it, she regained her confidence.

Clinician Support Critical to HPV Vaccination
MedPage Today – Feb. 20

Primary care providers have yet to get onboard with HPV immunization with their critical recommendation to patients or parents. Enthusiasm for HPV vaccination also has taken a hit because of its portrayal as a means to prevent a sexually transmitted disease (STD) instead of a vaccine to prevent cancer, speakers said during an HPV vaccination “summit” at Moffitt Cancer Center in Tampa, Fla.

Learn cancer facts, tips
Tampa Bay Times – Feb. 20

Moffitt Cancer Center and Florida Commissioner of Agriculture Adam Putnam are teaming up on a public education campaign aimed at preventing cancer. Created by the Florida Department of Agriculture and Consumer Services, “Living Healthy in Florida” provides tips on healthy living. Moffitt will take that initiative to another level, adding more advanced information about prevention, Putnam said in a news release. Cancer is the leading cause of death in Florida.

This week, HPV, cancer and the vaccine that could prevent them both
Radio Health Journal – February 2015

“It’s something that is typically transmitted sexually, but affects the majority of the population. So it’s not one of those things that oh it’s only those folks. At some point, most adult men and women will have an HPV infection in their lifetime.” That’s Dr. Susan Vadaparampil, a senior member of the Division of Populations Sciences at the Moffitt Cancer Center in Tampa, Florida.

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.

Please click here to view news releases featuring the cancer center.


 
 
 
TOOLS:   Font Size small font resizer separator font resizer separator big font resizer
 |  Site Map  |  Privacy Policy  |  Terms and Conditions